Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Globus Medical Inc (NY: GMED )

69.12 +0.33 (+0.48%)
Streaming Delayed Price Updated: 10:33 AM EDT, Aug 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 56,202
Open 68.79
Bid (Size) 69.02 (2)
Ask (Size) 69.12 (3)
Prev. Close 68.79
Today's Range 68.60 - 69.45
52wk Range 43.38 - 74.21
Shares Outstanding 135,407,017
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors
From Law Offices of Frank R. Cruz
Via Business Wire

Performance

YTD
+30.02%
+30.02%
1 Month
-4.19%
-4.19%
3 Month
+8.08%
+8.08%
6 Month
+29.08%
+29.08%
1 Year
+23.06%
+23.06%

More News

Read More
What 8 Analyst Ratings Have To Say About Globus Medical
Via Benzinga
Globus Medical (GMED) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
NYSE:GMED is showing decent growth, but is still valued reasonably.
Via Chartmill
Peering Into Globus Medical's Recent Short Interest
Via Benzinga
Where Globus Medical Stands With Analysts
Via Benzinga
GMED Stock Earnings: Globus Medical Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Globus Medical Reports Second Quarter 2024 Results
From Globus Medical
Via GlobeNewswire
Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System
From Globus Medical
Via GlobeNewswire
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
NYSE:GMED is not too expensive for the growth it is showing.
Via Chartmill
Deep Dive Into Globus Medical Stock: Analyst Perspectives (7 Ratings)
Via Benzinga
For those who appreciate growth without the sticker shock, NYSE:GMED is worth considering.
Via Chartmill
Staar Surgical Stock Earns RS Rating Upgrade
Via Investor's Business Daily
Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React
Via Benzinga
Topics Economy
Exposures Interest Rates
Stryker Stock Sees RS Rating Treks Higher To 71
Via Investor's Business Daily
CrowdStrike To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Key Takeaways From Globus Medical Analyst Ratings
Via Benzinga
Don't overlook NYSE:GMED—a stock with solid growth prospects and a reasonable valuation.
Via Chartmill
This Micron Technology Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Today
Via Benzinga
Globus Medical Shares Race Higher After Better-Than-Expected Q1 Results
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Louisiana-Pacific Posts Upbeat Results, Joins Cricut, Elanco Animal, American Public Education And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.